The high expression of SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 can be used as a potential prognostic indicator for improving survival and prognosis in ccRCC patients. This evidence concerns the gene SLC22A13 and nonpapillary renal cell carcinoma.